Showing 2,341 - 2,360 results of 16,814 for search '"cancer"', query time: 0.11s Refine Results
  1. 2341

    Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer by Yuankui Zhu, Yaxi Yang, Linghe Yue, Lei Wan, Xuqian Ma, Qing Yang, Xuan Tian, Yuguan Li, Ke Wang, Shaozhong Wei, Shaozhong Wei, Shaozhong Wei, Dianbao Zuo, Mingqian Feng, Mingqian Feng

    Published 2025-02-01
    “…Current pancreatic cancer immunotherapy focused on alphabeta (αβ) T cells, either through CD3-engaged bispecific antibodies or CAR-T. …”
    Get full text
    Article
  2. 2342
  3. 2343
  4. 2344

    Disseminated M. bovis Infection and Vertebral Osteomyelitis following Immunotherapy for Bladder Cancer by Harpreet S. Gill, Suhas P. Dasari, Sarbagya Pandit, Thomas E. Ritter, Sushma B. Raju, Alexander R. Chartier, Pinky Jha

    Published 2020-01-01
    “…The use of BCG in immunotherapy for bladder cancer has been in practice for over 40 years. However, uncommon, serious complications can occur with the therapy. …”
    Get full text
    Article
  5. 2345

    Very Late Relapse of Testicular Tumour in Combination with Renal Cancer and Their Retroperitoneoscopic Removal by Mihály Murányi, Morshed Ali Salah, Béla Tállai, Mátyás Benyó, Tibor Flaskó

    Published 2011-01-01
    “…Late relapse of a testicular cancer is an uncommon occurrence. We report a case of late relapse of a testicular tumour combined with a renal cancer and their successful removal with retroperitoneoscopy. …”
    Get full text
    Article
  6. 2346

    Increased Chromosomal and Oxidative DNA Damage in Patients with Multinodular Goiter and Their Association with Cancer by Hamiyet Donmez-Altuntas, Fahri Bayram, Nazmiye Bitgen, Sibel Ata, Zuhal Hamurcu, Gulden Baskol

    Published 2017-01-01
    “…Thyroid nodules are a common clinical problem worldwide. Although thyroid cancer accounts for a small percentage of thyroid nodules, the majority are benign. 8-Hydroxy-2′-deoxyguanosine (8-OHdG) levels are a marker of oxidative stress and play a key role in the initiation and development of a range of diseases and cancer types. …”
    Get full text
    Article
  7. 2347
  8. 2348

    Endocan in Cancers: A Lesson from a Circulating Dermatan Sulfate Proteoglycan by Maryse Delehedde, Lucie Devenyns, Claude-Alain Maurage, Romain R. Vivès

    Published 2013-01-01
    “…Consequently, Endocan expression has been associated with a growing number of pathological conditions where endothelium gets challenged and notably in highly vascularized cancers. In this context, Endocan has indeed been rapidly emerging as a promising tissue- and blood-based marker of the vascular growth and neoangiogenesis during cancer progression. …”
    Get full text
    Article
  9. 2349
  10. 2350
  11. 2351
  12. 2352
  13. 2353
  14. 2354
  15. 2355
  16. 2356

    Breast Cancer Imaging Using the Near-Infrared Fluorescent Agent, CLR1502 by Melissa L. Korb, Jason M. Warram, Joseph Grudzinski, Jamey Weichert, Justin Jeffery, Eben L. Rosenthal

    Published 2015-01-01
    “…Positive margins after breast conservation surgery represent a significant problem in the treatment of breast cancer. The near-infrared fluorescence agent CLR1502 (Cellectar Biosciences, Madison, WI) was studied in a preclinical breast cancer model to determine imaging properties and ability to detect small islands of malignancy. …”
    Get full text
    Article
  17. 2357

    Conjugated Linoleic Acid Treatment Attenuates Cancerous features in Hepatocellular Carcinoma Cells by Zohre Miri-Lavasani, Shukoofeh Torabi, Roya Solhi, Bahareh Shokouhian, Parvaneh Afsharian, Zahra Heydari, Abbas Piryaei, Zahra Farzaneh, Nikoo Hossein-khannazer, Hamidreza Aboulkheyr Es, Ensieh Zahmatkesh, Andreas Nussler, Moustapha Hassan, Mustapha Najimi, Massoud Vosough

    Published 2022-01-01
    “…Hepatocyte nuclear factor 4 alpha (HNF4α) is the key hepatogenesis transcription factor and its upregulation may decrease the invasiveness of cancerous cells by suppressing epithelial-mesenchymal transition (EMT). …”
    Get full text
    Article
  18. 2358
  19. 2359

    Levo-Tetrahydropalmatine Attenuates Bone Cancer Pain by Inhibiting Microglial Cells Activation by Mao-yin Zhang, Yue-peng Liu, Lian-yi Zhang, Dong-mei Yue, Dun-yi Qi, Gong-jian Liu, Su Liu

    Published 2015-01-01
    “…The present study is to investigate the analgesic roles of L-THP in rats with bone cancer pain caused by tumor cell implantation (TCI). …”
    Get full text
    Article
  20. 2360

    New methods of treatment for severe and moderate postoperative pain syndrome in patients with cancer by D.V. Dmytriiev, M.M. Barsa

    Published 2024-11-01
    “…Objective: to evaluate the clinical efficacy and safety of a medicinal product with active ingredient dinalbuphine sebacate (150 mg/2 ml) in patients with moderate to severe pain syndrome following reconstructive mammoplasty due to breast cancer surgery. Materials and methods. This was a multicenter, randomized, prospective, open-label study involving 60 inpatients who underwent mammoplasty as a result of breast cancer surgery. …”
    Get full text
    Article